(a) Specifications. Each capsule contains 221, 442, 884, or 1,768 milligrams (mg); or 4.42 grams of n -butyl chloride.
(b) Sponsors. See sponsors in § 510.600(c) of this chapter:
(1) No. 023851 for capsules containing 221, 442, 884, or 1,768 mg, or 4.42 grams (g); and
(2) No. 054771 for capsules containing 221 mg.
(c) Conditions of use in dogs - (1) Amount. Administer capsules orally based on body weight as follows:
(i) Capsules containing 221 mg: Under 5 pounds, 1 capsule per 1
1/4 pounds of body weight.
(ii) Capsules containing 442 mg: Under 5 pounds, 1 capsule per 2
1/2 pounds of body weight.
(iii) Capsules containing 884 mg:
(A) Under 5 pounds, 1 capsule;
(B) 5 to 10 pounds, 2 capsules;
(C) 10 to 20 pounds, 3 capsules;
(D) 20 to 40 pounds, 4 capsules;
(E) Over 40 pounds, 5 capsules.
(iv) Capsules containing 1,768 mg: Dogs weighing 5 to 10 pounds, 1 capsule.
(v) Capsules containing 4.42 g: Dogs weighing 40 pounds or over, 1 capsule.
(2) Indications for use. For the removal of ascarids (Toxocara canis and Toxascaris leonina ) and hookworms (Ancylostoma caninum, Ancylostoma braziliense, and Uncinaria stenocephala ) from dogs.
(3) Limitations. Dogs should not be fed for 18 to 24 hours before being given the drug. Administration of the drug should be followed in
1/2 to 1 hour with a mild cathartic. Normal feeding may be resumed 4 to 8 hours after treatment. Animals subject to reinfection may be retreated in 2 weeks. A veterinarian should be consulted before using in severely debilitated dogs.
[86 FR 10819, Feb. 23, 2021]
|